The grand venture of devolution has descended into a grim national fatalism By Chris Deerin I attended my first Christmas party of the year this week, a noisy mix of hacks, flacks, business folk and ...

SciNeuro has received funding of $5M from The Michael J. Fox Foundation for Parkinson's Research, as part of MJFF's Therapeutics Pipeline Program, to accelerate the preclinical development of the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. With health care in the news more often than ever, we are ...

SAN FRANCISCO – Spacedock, a Silicon Valley startup formerly known as Orbital Outpost X, announced plans Aug. 20 for a 2026 in-space demonstration of a universal connector for space systems. Working ...

Joe Guiles, PhD, is Head of Chemical Development at Agilent Technologies. With extensive pharma and biotech experience, he leads development for clinical and commercial stage therapeutic APIs. Over ...

Institutional special needs plans (I-SNP) are specialized Medicare Advantage plans for people who live in a care facility for at least 90 days or those who live in the community and require the care ...

Delivering cutting-edge peer-reviewed research on using nucleic acids and related compounds to alter gene expression for therapeutic purposes. A new article in the peer-reviewed journal Nucleic Acid ...

The 2025 NFL schedule released Wednesday evening, with the league announcing its full 272-game slate for the upcoming season. And the calendar is chock-full of anticipated matchups, including the ...

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio. Oligonucleotides work as short ...